Enhanced antifungal activity of fluconazole conjugated with Cu-Ag-ZnO nanocomposite

Hajjeh, 2004, Incidence of bloodstream infections due to Candida sp. and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program, J. Clin. Microbiol., 42, 1519, 10.1128/JCM.42.4.1519-1527.2004 Pfaller, 2004, Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus, J. Clin. Microbiol., 42, 4419, 10.1128/JCM.42.10.4419-4431.2004 Krcmery, 2002, Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance, J. Hosp. Infect., 50, 243, 10.1053/jhin.2001.1151 Cheng, 2004, Distribution and antifungal susceptibility of Candida sp. causing candidemia from 1996 to 1999, Diagn. Microbiol. Infect. Dis., 48, 33, 10.1016/j.diagmicrobio.2003.08.002 Yang, 2004, In vitro activity of voriconazole against Candida sp. isolated in Taiwan, Int. J. Antimicrob. Agents, 24, 294, 10.1016/j.ijantimicag.2004.01.014 Redding, 2000, The epidemiology of non-albicans Candida in oropharyngeal candidiasis in HIV patients, Spec. Care Dentist., 20, 178, 10.1111/j.1754-4505.2000.tb00015.x Warnock, 2006, Fungal diseases: an evolving public health challenge, Med. Mycol., 44, 697, 10.1080/13693780601009493 Wisplinghoff, 2004, Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study, Clin. Infect. Dis., 39, 309, 10.1086/421946 Zaoutis, 2005, The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis, Clin. Infect. Dis., 41, 1232, 10.1086/496922 Agarwal, 2004, Trends in neonatal septicemia: emergence of non-albicans Candida, Indian Pediatr., 41, 712 Jabra-Rizk, 2004, Fungal biofilms and drug resistance, Emerg. Infect. Dis., 10, 14, 10.3201/eid1001.030119 Orozco, 1998, Mechanism of fluconazole resistance in Candida krusei, Antimicrob. Agents Chemother., 42, 2645, 10.1128/AAC.42.10.2645 Marr, 2000, Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole, J. Infect. Dis., 181, 30, 10.1086/315193 Panyam, 2003, Biodegradable nanoparticles for drug and gene delivery to cells and tissue, Adv. Drug Deliv. Rev., 24, 329, 10.1016/S0169-409X(02)00228-4 Gurunathan, 2012, Oxidative stress-mediated antibacterial activity of graphene oxide and reduced graphene oxide in Pseudomonas aeruginosa, Int. J. Nanomedicine, 7, 5901, 10.2147/IJN.S37397 Nagy, 2011, Silver nanoparticles embedded in zeolite membranes: release of silver ions and mechanism of antibacterial action, Int. J. Nanomedicine, 6, 1833 Y H Leung, 2014, Mechanisms of antibacterial activity of MgO: non-ROS mediated toxicity of MgO nanoparticles towards Escherichia coli, Small., 10, 1171, 10.1002/smll.201302434 Selvaraj, 2014, Highly potential antifungal activity of quantum-sized silver nanoparticles against Candida albicans, Appl. Biochem. Biotechnol., 173, 55, 10.1007/s12010-014-0782-9 Wady, 2012, Evaluation of Candida albicans adhesion and biofilm formation on a denture base acrylic resin containing silver nanoparticles, J. Appl. Microbiol., 112, 1163, 10.1111/j.1365-2672.2012.05293.x Sun. Qi, Li. Jianmei, Le. Tao, Zinc oxide nanoparticle as a novel class of antifungal agents: current advances and future perspectives. J. Agric. Food Chem., 66(43), 11209–11220. da Frota, 2018, Synergistic effect of polyene antifungals and silver nanoparticles against Candida parapsilosis, Journal of Antibiotics Research., 2, 2574 Sapkota, 2011, Zinc oxide nanorod mediated visible light photoinactivation of model microbes in water, Nanotechnology, 22, 10.1088/0957-4484/22/21/215703 Barad, 2017, Preparation and characterization of ZnO nanoparticles coated by chitosan-linoleic acid; fungal growth and biofilm assay, Bratislavsk Lekarske Listy., 118, 169 Sharma, 2016, Synergistic activity of doped zinc oxide nanoparticles with antibiotics: ciprofloxacin, ampicillin, fluconazole and amphotericin B against pathogenic microorganisms, An. Acad. Bras. Cienc., 88, 1689, 10.1590/0001-3765201620150713 Huskar, 2015, Copper and copper-containing pesticides: metabolism, toxicity and oxidative stress, Journal of Vasyl Stefanyk Precarpathian National University., 2, 38, 10.15330/jpnu.2.1.38-50 Goa, 1995, Fluconazole, an update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients, Drugs., 50, 658, 10.2165/00003495-199550040-00007 Pfaller, 2006, Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing, Clin. Microbiol. Rev., 19, 435, 10.1128/CMR.19.2.435-447.2006 Sharma, 2015, Fluconazole loaded cubosomal vesicles for topical delivery, International Journal of Drug Development and Research., 7, 032 Singh, 2011, Development and validation of different UV-spectrophotometric methods for the estimation of fluconazole in bulk and in solid dosage form, Indian Journal of Chemical Technology., 18, 357 2019, CIDRAP News, 19 Tavallaee, 2009, Fixed drug eruption resulting from fluconazole use: a case report, J. Med. Case Rep., 3, 7368, 10.4076/1752-1947-3-7368 Fluconazole (Diflucan), 2016 Litt, 2005 Åkerman, 2002, Nonocrystal targeting in vivo, PNAS., 99, 12617, 10.1073/pnas.152463399 Weir, 2008, The use of nanoparticles in anti-microbial materials and their characterization, Analyst., 133, 835, 10.1039/b715532h Louis, 1944, Simplified technique for the agar cup assay of penicillin, J. Bacteriol., 47, 402, 10.1128/JB.47.4.402-403.1944 Jennifer, 2001, Determination of minimum inhibitory concentrations, J. Antimicrob. Chemother., 48, 5, 10.1093/jac/48.suppl_1.5 Mosmann, 1983, Rapid colourimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays, J. Immunol. Methods, 65, 55, 10.1016/0022-1759(83)90303-4 Young, 1982, Profile shape functions in Rietveld refinements, J.Appl. Crystallogr., 15, 430, 10.1107/S002188988201231X L. Lutterotti, MAUD version 2.70 <http://maud.radiographema.eu>. Rietveld, 1967, Line profiles of neutron powder-diffraction peaks for structure refinement, Acta Crystallogr., 22, 151, 10.1107/S0365110X67000234 Rietveld, 1969, A profile refinement method for nuclear and magnetic structures, J. Appl. Crystallogr., 2, 65, 10.1107/S0021889869006558 Kundu, 2017, Microstructure characterization of hydrothermally synthesized PANI/V2O5·nH2O heterojunction photocatalyst for visible light induced photodegradation of organic pollutants and non-absorbing colourless molecules, J. Hazard. Mater., 339, 161, 10.1016/j.jhazmat.2017.06.034 Caira, 2004, Preparation and crystal characterization of a polymorph, a monohydrate, and an ethyl acetate solvate of the antifungal fluconazole, J. Pharm. Sci., 93, 601, 10.1002/jps.10541 Chandrasekaran, 2015, Structural, spectral, thermodynamical, NLO, HOMO, LUMO and NBO analysis of fluconazole, Spectrochim. Acta A Mol. Biomol. Spectrosc., 1425, 00732 Anwar, 2019, Gold nanoparticles conjugation enhances antiacanthamoebic properties of nystatin, fluconazole and amphotericin B, J. Microbiol. Biotechnol., 29, 171, 10.4014/jmb.1805.05028